$4.040
-0.010 (-0.25%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de AVIR por análisis de gráficos similares
Alphio's AVIR stock price prediction model matches the current Atea Pharmaceuticals, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.13 (+2.17%). The 1-week path is $3.94 (-2.40%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Atea Pharmaceuticals, Inc.?
Atea Pharmaceuticals Inc is currently not a strong buy due to its low RSI of 15.657, indicating it is oversold, and a current price of $4.04, which is below the Fibonacci Pivot level of $4.527. However, the stock has shown a year-to-date change of +16.09% and a one-year change of +24.31%, suggesting potential for recovery. The main risk is the negative earnings trend, with an EPS of -0.41 reported in the last quarter, which could affect future performance.
AVIR cerró en $4.04 el Friday, tras bajar -0.25%
Atea Pharmaceuticals, Inc. (AVIR) last closed at $4.04, losing -0.25%. These facts feed the 1-day and 1-week AVIR price prediction above.
Factores de la previsión
Los factores de la previsión de Atea Pharmaceuticals, Inc. (AVIR) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de AVIR, ordenadas por similitud.
Análisis de estacionalidad de AVIR
Historically the probability of a positive October return for AVIR is 63.49%. August offers the highest probability of a positive month at 96.88%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de AVIR
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $3.37 | $3.37 | $3.62 | -16.54% |
| Nov 2026 | $3.95 | $4.06 | $4.59 | +0.43% |
| Dec 2026 | $3.53 | $3.58 | $4.03 | -11.44% |
En 2026, se proyecta que Atea Pharmaceuticals, Inc. (AVIR) oscile entre $3.37 y $4.59.
Previsión mensual de Atea Pharmaceuticals, Inc. para 2026
En Oct de 2026, se proyecta que Atea Pharmaceuticals, Inc. promedie $3.37, con un mínimo de $3.37 y un máximo de $3.62.
En Nov de 2026, se proyecta que Atea Pharmaceuticals, Inc. promedie $4.06, con un mínimo de $3.95 y un máximo de $4.59.
En Dec de 2026, se proyecta que Atea Pharmaceuticals, Inc. promedie $3.58, con un mínimo de $3.53 y un máximo de $4.03.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.